Immunotoxicity, genotoxicity and epigenetic toxicity of nanomaterials: New strategies for toxicity testing?
暂无分享,去创建一个
Maria Dusinska | Eva Rollerova | Jana Tulinska | Elise Rundén-Pran | Naouale El Yamani | M. Dusinska | M. Kuricová | B. Smolková | Miroslava Kuricova | Aurelia Liskova | Bozena Smolkova | E. Rollerová | N. el Yamani | J. Tulinská | A. Líšková | E. Rundén-Pran | E. Rollerova | J. Tulinska
[1] A. Vcev,et al. Approaches and Considerations for the Successful Treatment of HCV Infection , 2017 .
[2] B. Sanderson,et al. Cyto- and genotoxicity of ultrafine TiO2 particles in cultured human lymphoblastoid cells. , 2007, Mutation research.
[3] M. J. Silva,et al. Fibrous shape underlies the mutagenic and carcinogenic potential of nanosilver while surface chemistry affects the biosafety of iron oxide nanoparticles , 2017, Mutagenesis.
[4] Å. Sidén,et al. Cytotoxic Effects of Tetracycline Analogues (Doxycycline, Minocycline and COL-3) in Acute Myeloid Leukemia HL-60 Cells , 2014, PloS one.
[5] Chenhao Zhou,et al. The various aspects of genetic and epigenetic toxicology: testing methods and clinical applications , 2017, Journal of Translational Medicine.
[6] D. Deobagkar,et al. Epigenetic modulation upon exposure of lung fibroblasts to TiO2 and ZnO nanoparticles: alterations in DNA methylation , 2016, International journal of nanomedicine.
[7] F. Nesslany. Unscheduled DNA synthesis (UDS) test with mammalian liver cells in vivo. , 2013, Methods in molecular biology.
[8] Antonio Marcomini,et al. Grouping and Read-Across Approaches for Risk Assessment of Nanomaterials , 2015, International journal of environmental research and public health.
[9] J. Zelikoff,et al. Tumor challenges in immunotoxicity testing. , 2010, Methods in molecular biology.
[10] S. Schürch,et al. Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. , 2006, Environmental science & technology.
[11] Satyajit Mayor,et al. Pathways of clathrin-independent endocytosis , 2007, Nature Reviews Molecular Cell Biology.
[12] R. Luebke. Immunotoxicant Screening and Prioritization in the Twenty-first Century , 2012, Toxicologic pathology.
[13] Clay W Scott,et al. Human induced pluripotent stem cells and their use in drug discovery for toxicity testing. , 2013, Toxicology letters.
[14] R. Mariani-Costantini,et al. Immunotoxicity of nanoparticles. , 2011, International journal of immunopathology and pharmacology.
[15] J. Greally,et al. In vitro and in vivo testing methods of epigenomic endpoints for evaluating endocrine disruptors. , 2013, ALTEX.
[16] N. Luciani,et al. In vivo biodistribution and biological impact of injected carbon nanotubes using magnetic resonance techniques , 2011, International journal of nanomedicine.
[17] Awadhesh N Jha,et al. Ecotoxicological applications and significance of the comet assay. , 2008, Mutagenesis.
[18] Hiroki R Ueda,et al. Whole-body and Whole-Organ Clearing and Imaging Techniques with Single-Cell Resolution: Toward Organism-Level Systems Biology in Mammals. , 2016, Cell chemical biology.
[19] Katsuhide Fujita,et al. Reliable size determination of nanoparticles using dynamic light scattering method for in vitro toxicology assessment. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.
[20] P. Hoet,et al. Interactions of nanomaterials with the immune system. , 2012, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[21] V. Patravale,et al. Toxicological evaluation of pH-sensitive nanoparticles of curcumin: acute, sub-acute and genotoxicity studies. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[22] G. Nienhaus,et al. Toward a molecular understanding of nanoparticle–protein interactions , 2012, Biophysical Reviews.
[23] Parag Aggarwal,et al. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. , 2008, Molecular pharmaceutics.
[24] R. Singh,et al. Alternative Modes of Binding of Recombinant Human Histone Deacetylase 8 to Colloidal Gold Nanoparticles. , 2008, Journal of biomedical nanotechnology.
[25] R. Marcos,et al. Frozen dispersions of nanomaterials are a useful operational procedure in nanotoxicology , 2017, Nanotoxicology.
[26] Maria Dusinska,et al. NanoGenotoxicology: present and the future. , 2017, Mutagenesis.
[27] A Worth,et al. Towards an alternative testing strategy for nanomaterials used in nanomedicine: Lessons from NanoTEST , 2015, Nanotoxicology.
[28] Youhei Sato,et al. Characteristics of the transformation frequency at the tumor promotion stage of airborne particulate and gaseous matter at ten sites in Japan. , 2013, Environmental science. Processes & impacts.
[29] Miao He,et al. Comparative and Mechanistic Genotoxicity Assessment of Nanomaterials via a Quantitative Toxicogenomics Approach across Multiple Species , 2014, Environmental science & technology.
[30] Ken Donaldson,et al. Possible genotoxic mechanisms of nanoparticles: Criteria for improved test strategies , 2010, Nanotoxicology.
[31] Marina A Dobrovolskaia,et al. Nanoparticles and the immune system. , 2010, Endocrinology.
[32] M. LeBaron,et al. Epigenetic screening in product safety assessment: are we there yet? , 2011, Toxicology mechanisms and methods.
[33] Albert Duschl,et al. Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects , 2011, Particle and Fibre Toxicology.
[34] D. Lawrence,et al. Dendritic cells in immunotoxicity testing. , 2010, Methods in molecular biology.
[35] R. Luebke. Parasite challenge as host resistance models for immunotoxicity testing. , 2010, Methods in molecular biology.
[36] E. Corsini,et al. Evaluating cytokines in immunotoxicity testing. , 2010, Methods in molecular biology.
[37] B. Zeigler,et al. Validation of an eight parameter immunophenotyping panel in adult canines for assessment of immunotoxicity. , 2013, Veterinary immunology and immunopathology.
[38] M. Dusinska,et al. Impact of nanosilver on various DNA lesions and HPRT gene mutations – effects of charge and surface coating , 2015, Particle and Fibre Toxicology.
[39] H. Vohr,et al. Specific antibody responses of primary cells from different cell sources are able to predict immunotoxicity in vitro. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.
[40] Ji-Eun Lee,et al. The delayed type hypersensitivity assay using protein and xenogeneic cell antigens. , 2010, Methods in molecular biology.
[41] Shelley E. Brown,et al. Quantum dot-induced epigenetic and genotoxic changes in human breast cancer cells , 2008, Journal of Molecular Medicine.
[42] P. Apostoli,et al. Titanium dioxide aggregating nanoparticles induce autophagy and under-expression of microRNA 21 and 30a in A549 cell line: A comparative study with cobalt(II, III) oxide nanoparticles. , 2017, Toxicology in vitro : an international journal published in association with BIBRA.
[43] H. Loveren,et al. Successful validation of genomic biomarkers for human immunotoxicity in Jurkat T cells in vitro , 2015, Journal of applied toxicology : JAT.
[44] Iseult Lynch,et al. Quantification of nanoparticle uptake by cells using an unbiased sampling method and electron microscopy. , 2011, Nanomedicine.
[45] Maria Dusinska,et al. Testing strategies for the safety of nanoparticles used in medical applications. , 2009, Nanomedicine.
[46] Leaf Huang,et al. Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[47] R. Khanna,et al. T cell recognition , 2016 .
[48] Meirong Zhao,et al. Effects of titanium dioxide nano-particles on growth and some histological parameters of zebrafish (Danio rerio) after a long-term exposure. , 2011, Aquatic toxicology.
[49] Maria Dusinska,et al. Health effects of selected nanoparticles in vivo: liver function and hepatotoxicity following intravenous injection of titanium dioxide and Na-oleate-coated iron oxide nanoparticles in rodents , 2015, Nanotoxicology.
[50] W. Schoonen,et al. High‐Throughput Toxicity Testing in Drug Development: Aims, Strategies, and Novel Trends , 2013 .
[51] Gunnar Brunborg,et al. High-throughput comet assay using 96 minigels. , 2013, Mutagenesis.
[52] Maria Dusinska,et al. Can the comet assay be used reliably to detect nanoparticle‐induced genotoxicity? , 2015, Environmental and molecular mutagenesis.
[53] Maria Dusinska,et al. Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles , 2014, Nanotoxicology.
[54] Jacques Descotes,et al. Evaluation of a Lymph Node Proliferation Assay for its Ability to Detect Pharmaceuticals with Potential to Cause Immune-Mediated Drug Reactions , 2005, Journal of immunotoxicology.
[55] Yueyuan Chen,et al. Silver nanoparticle-induced hemoglobin decrease involves alteration of histone 3 methylation status. , 2015, Biomaterials.
[56] Maria Dusinska,et al. Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests , 2015, Nanotoxicology.
[57] Pu Wang,et al. Zinc oxide nanoparticles-induced epigenetic change and G2/M arrest are associated with apoptosis in human epidermal keratinocytes , 2016, International journal of nanomedicine.
[58] Joachim Heinrich,et al. Influence of indoor factors in dwellings on the development of childhood asthma. , 2011, International journal of hygiene and environmental health.
[59] J. Yates,et al. Systematic identification of C. elegans miRISC proteins, miRNAs, and mRNA targets by their interactions with GW182 proteins AIN-1 and AIN-2. , 2007, Molecular cell.
[60] T. Hartung,et al. Immunotoxicology: challenges in the 21st century and in vitro opportunities. , 2013, ALTEX.
[61] Haitao Wang,et al. MicroRNAs as participants in cytotoxicity of CdTe quantum dots in NIH/3T3 cells. , 2011, Biomaterials.
[62] Peter Wick,et al. The automated FADU-assay, a potential high-throughput in vitro method for early screening of DNA breakage. , 2011, ALTEX.
[63] D. Gurwitz,et al. Characterization of human lymphoblastoid cell lines as a novel in vitro test system to predict the immunotoxicity of xenobiotics. , 2015, Toxicology letters.
[64] K. White,et al. The sheep erythrocyte T-dependent antibody response (TDAR). , 2010, Methods in molecular biology.
[65] A. Collins,et al. Nanoparticles in food. Epigenetic changes induced by nanomaterials and possible impact on health. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[66] H. van Loveren,et al. Assessment of the usefulness of the murine cytotoxic T cell line CTLL-2 for immunotoxicity screening by transcriptomics. , 2013, Toxicology letters.
[67] M. Collinge,et al. Human lymphocyte activation assay: An in vitro method for predictive immunotoxicity testing , 2010, Journal of immunotoxicology.
[68] P. M. Williams,et al. Confounding experimental considerations in nanogenotoxicology. , 2009, Mutagenesis.
[69] Maria Dusinska,et al. Impact of agglomeration and different dispersions of titanium dioxide nanoparticles on the human related in vitro cytotoxicity and genotoxicity. , 2012, Journal of environmental monitoring : JEM.
[70] H. van Loveren,et al. Transcriptomic profile indicative of immunotoxic exposure: in vitro studies in peripheral blood mononuclear cells. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[71] Stephen J. Evans,et al. Critical review of the current and future challenges associated with advanced in vitro systems towards the study of nanoparticle (secondary) genotoxicity , 2016, Mutagenesis.
[72] Marina A Dobrovolskaia,et al. Evaluation of nanoparticle immunotoxicity. , 2009, Nature nanotechnology.
[73] M. Dobrovolskaia,et al. Immunological properties of engineered nanomaterials , 2007, Nature Nanotechnology.
[74] L. Gribaldo,et al. In vitro bone marrow granulocyte-macrophage progenitor cultures in the assessment of hematotoxic potential of the new drugs , 2004, Cell Biology and Toxicology.
[75] F. Burleson,et al. Host resistance assays including bacterial challenge models. , 2010, Methods in molecular biology.
[76] N. Chatterjee,et al. Integrated mRNA and micro RNA profiling reveals epigenetic mechanism of differential sensitivity of Jurkat T cells to AgNPs and Ag ions. , 2014, Toxicology letters.
[77] Max Costa,et al. Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium. , 2009, Metallomics : integrated biometal science.
[78] Z. Arslan,et al. Chronic exposure to nanosized, anatase titanium dioxide is not cyto‐ or genotoxic to Chinese hamster ovary cells , 2011, Environmental and molecular mutagenesis.
[79] Marianne Geiser,et al. Update on macrophage clearance of inhaled micro- and nanoparticles. , 2010, Journal of aerosol medicine and pulmonary drug delivery.
[80] G. Koekemoer,et al. Assessing the DNA methylation status of single cells with the comet assay. , 2010, Analytical biochemistry.
[81] G. Brunborg,et al. Twelve-gel slide format optimised for comet assay and fluorescent in situ hybridisation. , 2010, Toxicology letters.
[82] P. Borm,et al. Testing Strategies to Establish the Safety of Nanomaterials: Conclusions of an ECETOC Workshop , 2007, Inhalation toxicology.
[83] Y. Dragan,et al. What do we need to know prior to thinking about incorporating an epigenetic evaluation into safety assessments? , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[84] Lang Tran,et al. ITS-NANO - Prioritising nanosafety research to develop a stakeholder driven intelligent testing strategy , 2014, Particle and Fibre Toxicology.
[85] Helinor Johnston,et al. Development of in vitro systems for nanotoxicology: methodological considerations , 2009, Critical reviews in toxicology.
[86] Phil Sayre,et al. Review of achievements of the OECD Working Party on Manufactured Nanomaterials' Testing and Assessment Programme. From exploratory testing to test guidelines. , 2016, Regulatory toxicology and pharmacology : RTP.
[87] Maria Dusinska,et al. Towards a Consensus View on Understanding Nanomaterials Hazards and Managing Exposure: Knowledge Gaps and Recommendations , 2013, Materials.
[88] Francesco Salvatore,et al. The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. , 2016, Nanomedicine.
[89] Parag Aggarwal,et al. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. , 2009, Advanced drug delivery reviews.
[90] Bengt Fadeel,et al. Mechanisms of carbon nanotube-induced toxicity: focus on pulmonary inflammation. , 2013, Advanced drug delivery reviews.
[91] G. Jenkins,et al. In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines , 2012, Mutation research.
[92] O. Cuvier,et al. Dynamic chromatin technologies: from individual molecules to epigenomic regulation in cells , 2017, Nature Reviews Genetics.
[93] Albert Duschl,et al. The suitability of different cellular in vitro immunotoxicity and genotoxicity methods for the analysis of nanoparticle-induced events , 2010, Nanotoxicology.
[94] F. Rossi,et al. Genotoxicity and morphological transformation induced by cobalt nanoparticles and cobalt chloride: an in vitro study in Balb/3T3 mouse fibroblasts. , 2009, Mutagenesis.
[95] Amaya Azqueta,et al. The influence of scoring method on variability in results obtained with the comet assay. , 2011, Mutagenesis.
[96] Stefan Weigel,et al. International interlaboratory study for sizing and quantification of Ag nanoparticles in food simulants by single-particle ICPMS , 2014, Analytical and Bioanalytical Chemistry.
[97] Xiaoyuan Chen,et al. Color-tunable Gd-Zn-Cu-In-S/ZnS quantum dots for dual modality magnetic resonance and fluorescence imaging , 2014, Nano Research.
[98] Bengt Fadeel,et al. Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells. , 2011, Toxicology and applied pharmacology.
[99] Vasilis Ntziachristos,et al. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging , 2010, Particle and Fibre Toxicology.
[100] Marina A Dobrovolskaia,et al. Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[101] M. Goodisman,et al. DNA methylation is widespread and associated with differential gene expression in castes of the honeybee, Apis mellifera , 2009, Proceedings of the National Academy of Sciences.
[102] Iseult Lynch,et al. Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines. , 2011, Small.
[103] S. De Flora,et al. Transplacental clastogenic and epigenetic effects of gold nanoparticles in mice. , 2013, Mutation research.
[104] Steffen Loft,et al. Hazard identification of particulate matter on vasomotor dysfunction and progression of atherosclerosis , 2011, Critical reviews in toxicology.
[105] M. Dusinska,et al. Nanomedicine and epigenome. Possible health risks. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[106] Dwight Romanovicz,et al. Biodistribution and long-term fate of silver nanoparticles functionalized with bovine serum albumin in rats. , 2010, Metallomics : integrated biometal science.
[107] Maria Dusinska,et al. NanoTEST in a Nutshell , 2015, Nanotoxicology.
[108] The in vitro PIG-A gene mutation assay: mutagenicity testing via flow cytometry based on the glycosylphosphatidylinositol (GPI) status of TK6 cells , 2015, Archives of Toxicology.
[109] Blanca Suarez-Merino,et al. High throughput toxicity screening and intracellular detection of nanomaterials , 2016, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[110] P. Lappin,et al. Immune Modulator Studies in Primates: The Utility of Flow Cytometry and Immunohistochemistry in the Identification and Characterization of Immunotoxicity , 2003, Toxicologic pathology.
[111] So Yeong Lee,et al. Concentration-dependent fluorescence live-cell imaging and tracking of intracellular nanoparticles , 2011, Nanotechnology.
[112] Sumit Arora,et al. Nanotoxicology and in vitro studies: the need of the hour. , 2012, Toxicology and applied pharmacology.
[113] Armin Braun,et al. Assessment of immunotoxicity using precision-cut tissue slices , 2012, Xenobiotica; the fate of foreign compounds in biological systems.
[114] Maria Dusinska,et al. Iron oxide nanoparticle toxicity testing using high-throughput analysis and high-content imaging , 2015, Nanotoxicology.
[115] G. Pojana,et al. Immunotoxicity and genotoxicity testing of PLGA-PEO nanoparticles in human blood cell model , 2015, Nanotoxicology.
[116] R. Pieters,et al. The Use of In Vitro Systems for Evaluating Immunotoxicity: The Report and Recommendations of an ECVAM Workshop , 2005, Journal of immunotoxicology.
[117] George E Johnson,et al. Mammalian cell HPRT gene mutation assay: test methods. , 2012, Methods in molecular biology.
[118] W. Ong,et al. Short- and long-term changes in blood miRNA levels after nanogold injection in rats—potential biomarkers of nanoparticle exposure , 2012, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[119] Michael Weber,et al. Methylated DNA immunoprecipitation (MeDIP) from low amounts of cells. , 2012, Methods in molecular biology.
[120] I. Zuhorn,et al. Mechanism of polyplex- and lipoplex-mediated delivery of nucleic acids: real-time visualization of transient membrane destabilization without endosomal lysis. , 2013, ACS nano.
[121] Rui Hu,et al. A pilot study in non-human primates shows no adverse response to intravenous injection of quantum dots. , 2012, Nature nanotechnology.
[122] S. Seys,et al. Cyto-genotoxic and DNA methylation changes induced by different crystal phases of TiO2-np in bronchial epithelial (16-HBE) cells. , 2017, Mutation research.
[123] H. van Loveren,et al. In vitro testing for direct immunotoxicity: state of the art. , 2010, Methods in molecular biology.
[124] W. Reik,et al. Single-cell epigenomics: powerful new methods for understanding gene regulation and cell identity , 2016, Genome Biology.
[125] M. Garnett,et al. Nanomedicines and nanotoxicology: some physiological principles. , 2006, Occupational medicine.
[126] Markus Schulz,et al. Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations--many questions, some answers. , 2009, Mutation research.
[127] A. Collins,et al. In vitro genotoxicity testing of four reference metal nanomaterials, titanium dioxide, zinc oxide, cerium oxide and silver: towards reliable hazard assessment , 2017, Mutagenesis.
[128] M. Jennifer,et al. Nanoparticle Technology as a Double-Edged Sword: Cytotoxic, Genotoxic and Epigenetic Effects on Living Cells , 2013 .
[129] Maria Dusinska,et al. Suitability of human and mammalian cells of different origin for the assessment of genotoxicity of metal and polymeric engineered nanoparticles , 2015, Nanotoxicology.
[130] D. Herzyk,et al. The T-dependent antibody response to keyhole limpet hemocyanin in rodents. , 2010, Methods in molecular biology.
[131] M. Nagarkatti,et al. Evaluation of apoptosis in immunotoxicity testing. , 2010, Methods in molecular biology.
[132] J. Irudayaraj,et al. From the Cover: Zinc oxide Nanoparticles-Induced Reactive Oxygen Species Promotes Multimodal Cyto- and Epigenetic Toxicity , 2017, Toxicological sciences : an official journal of the Society of Toxicology.
[133] D. J. Lewis,et al. Intracellular synchrotron nanoimaging and DNA damage/genotoxicity screening of novel lanthanide-coated nanovectors. , 2010, Nanomedicine.
[134] S. Choudhuri,et al. Epigenetic targets of some toxicologically relevant metals: a review of the literature , 2012, Journal of applied toxicology : JAT.
[135] T. Mashino,et al. Biological safety of water-soluble fullerenes evaluated using tests for genotoxicity, phototoxicity, and pro-oxidant activity. , 2010, The Journal of toxicological sciences.
[136] Lisbeth E. Knudsen,et al. Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22 358 subjects in 11 countries , 2008, Carcinogenesis.
[137] R. Dietert,et al. The cytotoxic T lymphocyte assay for evaluating cell-mediated immune function. , 2010, Methods in molecular biology.
[138] Darrell R Boverhof,et al. Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: a workshop summary. , 2014, Regulatory toxicology and pharmacology : RTP.
[139] O. Hammarsten,et al. An optimized method for detecting gamma-H2AX in blood cells reveals a significant interindividual variation in the gamma-H2AX response among humans , 2007, Nucleic acids research.
[140] M. Simkó,et al. Nanoparticles, free radicals and oxidative stress , 2011 .
[141] Alberto L. Sangiovanni-Vincentelli,et al. Testing Strategies for the 1990's (Panel Abstract) , 1990, DAC.
[142] Stephen Mann,et al. Nanoparticles can cause DNA damage across a cellular barrier. , 2009, Nature nanotechnology.
[143] K. Lauber,et al. The role of defective clearance of apoptotic cells in systemic autoimmunity , 2010, Nature Reviews Rheumatology.
[144] David B Warheit,et al. Rationale of genotoxicity testing of nanomaterials: Regulatory requirements and appropriateness of available OECD test guidelines , 2010, Nanotoxicology.
[145] H. Ochs,et al. The T-cell-dependent antibody response assay in nonclinical studies of pharmaceuticals and chemicals: study design, data analysis, interpretation. , 2014, Regulatory toxicology and pharmacology : RTP.
[146] Barbara Witt,et al. Cytotoxicity and genotoxicity of nano - and microparticulate copper oxide: role of solubility and intracellular bioavailability , 2014, Particle and Fibre Toxicology.
[147] T. Gant,et al. Environmentally induced epigenetic toxicity: potential public health concerns , 2016, Critical reviews in toxicology.
[148] J. Klostergaard,et al. Magnetic nanovectors for drug delivery. , 2012, Maturitas.
[149] Sandra L. Schmid,et al. Regulated portals of entry into the cell , 2003, Nature.
[150] Wim H de Jong,et al. A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements , 2016, International journal of nanomedicine.
[151] W. Freebern. Viral host resistance studies. , 2010, Methods in molecular biology.
[152] Amaya Azqueta,et al. High throughput sample processing and automated scoring , 2014, Front. Genet..
[153] B. Bay,et al. Epigenetic mechanisms in nanomaterial-induced toxicity. , 2015, Epigenomics.
[154] R. Liu,et al. Comprehensive Evaluation of microRNA Expression Profiling Reveals the Neural Signaling Specific Cytotoxicity of Superparamagnetic Iron Oxide Nanoparticles (SPIONs) through N-Methyl-D-Aspartate Receptor , 2015, PloS one.
[155] D. Parent-Massin,et al. Prevalidation of a model for predicting acute neutropenia by colony forming unit granulocyte/macrophage (CFU-GM) assay. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.
[156] Francesco Stellacci,et al. Effect of surface properties on nanoparticle-cell interactions. , 2010, Small.
[157] J. Conde,et al. Chiral Antioxidant-based Gold Nanoclusters Reprogram DNA Epigenetic Patterns , 2016, Scientific Reports.
[158] Matthew Boyles,et al. Is the toxic potential of nanosilver dependent on its size? , 2014, Particle and Fibre Toxicology.
[159] E Ingham,et al. Signalling of DNA damage and cytokines across cell barriers exposed to nanoparticles depends on barrier thickness. , 2011, Nature nanotechnology.
[160] Adriele Prina-Mello,et al. Towards a nanospecific approach for risk assessment. , 2016, Regulatory toxicology and pharmacology : RTP.
[161] H. van Loveren,et al. Toxicogenomics-based identification of mechanisms for direct immunotoxicity. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.
[162] A. Collins,et al. The comet assay in human biomonitoring: gene-environment interactions. , 2008, Mutagenesis.
[163] M. Fenech,et al. Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. , 2011, Mutagenesis.
[164] Philip Demokritou,et al. High-Throughput Screening Platform for Engineered Nanoparticle-Mediated Genotoxicity Using CometChip Technology , 2014, ACS nano.
[165] A. Lewies,et al. Using a medium-throughput comet assay to evaluate the global DNA methylation status of single cells , 2014, Front. Genet..
[166] David H. Chen,et al. Genotoxicity of silver nanoparticles evaluated using the Ames test and in vitro micronucleus assay. , 2012, Mutation research.
[167] Iseult Lynch,et al. Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices , 2011, Nanotoxicology.
[168] A. Visconti,et al. T-2 toxin immunotoxicity on human B and T lymphoid cell lines. , 2005, Toxicology.
[169] Andreas Luch,et al. T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays , 2010, Cellular and Molecular Life Sciences.
[170] Xiang Zhou,et al. A review: microRNA detection methods. , 2015, Organic & biomolecular chemistry.